Clinical trials recruiting for Lung Neoplasms

Phase breakdown

Drugs and treatments being studied

Where trials are recruiting (top US states)

Top cities

Self-screener

Recruiting trials

• 3D Virtual Resection for Predicting Lung Function in VATS
  NCT07436598 · Phase: Not specified · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• A Phase Ⅱ Clinical Study of Adebrelimab Combined With Chemotherapy and Concurrent Radiotherapy for Extensive-Stage Oligometastatic SCLC
  NCT06177925 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• ALG-LungCancerRegistry (SAFRO2202)
  NCT07161882 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 21 locations
• Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma
  NCT06885697 · Phase: Phase 1 · Ages: 18 Years to 120 Years · Sex: All (male and female) · 1 location
• Association of Psychological Distress in Patients With Lung Cancer
  NCT06218901 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Benchmarking Large Language Models Against Tumour Boards for Oncology Treatment Recommendations
  NCT07739121 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Clinical Application Study of PET/CT for Differential Diagnosis of Non-small Cell Lung Cancer
  NCT07026110 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• Comparison of Segmentectomy Versus Lobectomy for Non-small Cell Lung Cancer ≤ 2 cm in the Middle Third of the Lung Field
  NCT04944563 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• DeniLA: Comprehensive Demographics and Clinical Profile of NSCLC Patients: Analyzing Guideline-Concordant Care in First-line Treatment Patterns
  NCT07109154 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · 7 locations
• Diagnosis of Multiple Cancer and Monitoring of Minimal Residual Tumors After Treatment Using Blood and High-Sensitivity Genetic Analysis Techniques
  NCT07035587 · Phase: Not specified · Ages: 19 Years and older · Sex: All (male and female) · 1 location
• Early Intervention Strategies for Lung Cancer
  NCT06988943 · Phase: Not applicable (e.g. observational or device study) · Ages: 40 Years to 74 Years · Sex: All (male and female) · 1 location
• Effect of Modified Arm Positioning on Shoulder Pain After Thoracoscopic Lobectomy
  NCT07746323 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Establishment of a Tumor Bank for Blood Samples
  NCT01763125 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 6 locations
• Establishment of a Tumor Bank for Tissue Samples
  NCT01789229 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 3 locations
• HTL0039732 in Participants With Advanced Solid Tumours
  NCT05944237 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 10 locations
• LUNG-ROLL: Treatment Patterns and Cost of Illness of Lung Cancer in Canada
  NCT07143110 · Phase: Not specified · Ages: 18 Years to 130 Years · Sex: All (male and female) · 2 locations
• Liquid Biopsy-Based Pre-Screening to Streamline LDCT Lung Cancer Screening in High-Risk Individuals
  NCT07358715 · Phase: Not applicable (e.g. observational or device study) · Ages: 21 Years to 75 Years · Sex: All (male and female) · 1 location
• Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54
  NCT04577599 · Phase: Not applicable (e.g. observational or device study) · Ages: 40 Years to 54 Years · Sex: All (male and female) · 1 location
• MDT-Based Umbrella Decision Model for Geriatric Lung Cancer Patients
  NCT07509333 · Phase: Not applicable (e.g. observational or device study) · Ages: 60 Years to 70 Years · Sex: All (male and female) · 1 location
• Mediastinal Lymph Node Dissection Versus Spared Mediastinal Lymph Node Dissection in Stage I GGN NSCLC
  NCT04631770 · Phase: Not applicable (e.g. observational or device study) · Ages: No age limits stated · Sex: All (male and female) · 1 location
• Methylation Profile Test (Methylscape) in Body Fluids for Multi-Cancer Detection and Monitoring in Colombia
  NCT07741435 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Molecular Analysis of Oncogenes and Resistance Mechanisms in Lung Cancer
  NCT01580982 · Phase: Not specified · Ages: 18 Years to 85 Years · Sex: All (male and female) · 1 location
• Nitride-Based Raman Biochip for Lung Cancer Diagnosis and Monitoring
  NCT07755020 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Perioperative Specimen Imaging Using High-resolution 18F-FDG-PET-CT During Thoracic Surgery: a Pilot Study
  NCT05693363 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Phase I Study of JYP0322 in ROS1 Fusion-Positive Solid Tumors
  NCT06128148 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Post-line Treatment With Teniposide for c-Myc-driven Extensive-stage Small Cell Lung Cancer
  NCT06758700 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Preventing Dato-DXd Associated Stomatitis With Dexamethasone Mouthwash, TROPION-DM
  NCT06974604 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Specimen Banking From Patients With Lung Cancer
  NCT01585675 · Phase: Not specified · Ages: 18 Years to 85 Years · Sex: All (male and female) · 1 location
• Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC
  NCT07489066 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 27 locations
• Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer
  NCT07476287 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 30 locations
• TELESCOPE- TELEhealth Shared Decision-making COaching
  NCT05491213 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• TELEhealth Shared Decision-making COaching for Lung Cancer Screening in Primary Care (TELESCOPE) for Hispanics
  NCT07165691 · Phase: Not applicable (e.g. observational or device study) · Ages: 50 Years to 77 Years · Sex: All (male and female) · 1 location
• To Conduct Multi-omics Integrated Studies in Peripheral Blood, Such as Fragment Omics, Metabolomics and Epigenetics, and Establish Non-invasive Dynamic Follow-up Monitoring Programs During Perioperative and Postoperative Periods (Observational Study)
  NCT07291921 · Phase: Not specified · Ages: 18 Years to 85 Years · Sex: All (male and female) · 1 location

Related conditions

Trials recruiting for Lung Neoplasms often also study these conditions. Each links to its own recruiting-trial list.

Common questions

Are these trials free to join?

Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.

How do I know if I am eligible for Lung Neoplasms trials?

Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.

Is this list complete?

No. For the full list, search ClinicalTrials.gov.